Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Zhejiang Shapuaisi Pharmaceutical Co Ltd cash flow reinvestment rate. Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a Cash Flow Reinvestment Rate of 4.07x as of September 2025, reinvesting CN¥34.84 Million (capex CN¥34.84 Million ) from operating cash flow of CN¥8.57 Million. Explore 603168 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Cash flow reinvestment rate of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. Historical reinvestment intensity for Zhejiang Shapuaisi Pharmaceutical Co Ltd across 17 annual periods. Explore reinvestment intensity of Zhejiang Shapuaisi Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2008–2024)
Zhejiang Shapuaisi Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2008 to 2024. Year-by-year capital reinvestment analysis for Zhejiang Shapuaisi Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 603168 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 7.90x | CN¥202.80 Million | CN¥25.67 Million | CN¥128.11 Million | ▲ +4.2% |
| 2023 | 7.58x | CN¥314.65 Million | CN¥41.49 Million | CN¥219.80 Million | ▲ +354.4% |
| 2022 | 1.67x | CN¥193.13 Million | CN¥115.72 Million | CN¥148.69 Million | ▼ -62.5% |
| 2021 | 4.45x | CN¥448.68 Million | CN¥100.78 Million | CN¥153.44 Million | ▲ +46.6% |
| 2020 | 3.04x | CN¥133.91 Million | CN¥44.09 Million | CN¥17.18 Million | ▲ +566.2% |
| 2019 | 0.46x | CN¥27.11 Million | CN¥59.47 Million | CN¥20.33 Million | ▼ -87.4% |
| 2018 | 3.62x | CN¥363.80 Million | CN¥100.37 Million | CN¥58.38 Million | ▼ -15.1% |
| 2017 | 4.27x | CN¥194.50 Million | CN¥45.57 Million | CN¥114.00 Million | ▲ +281.3% |
| 2016 | 1.12x | CN¥329.44 Million | CN¥294.33 Million | CN¥39.94 Million | ▼ -28.1% |
| 2015 | 1.56x | CN¥177.94 Million | CN¥114.27 Million | CN¥97.94 Million | ▲ +124.8% |
| 2014 | 0.69x | CN¥102.53 Million | CN¥147.99 Million | CN¥102.53 Million | ▲ +13.8% |
| 2013 | 0.61x | CN¥71.73 Million | CN¥117.86 Million | CN¥71.73 Million | ▼ -43.1% |
| 2012 | 1.07x | CN¥71.91 Million | CN¥67.27 Million | CN¥71.91 Million | ▼ -45.3% |
| 2011 | 1.95x | CN¥29.59 Million | CN¥15.14 Million | CN¥29.59 Million | ▲ +326.0% |
| 2010 | 0.46x | CN¥8.06 Million | CN¥17.57 Million | CN¥8.06 Million | ▲ +56.1% |
| 2009 | 0.29x | CN¥8.49 Million | CN¥28.87 Million | CN¥8.49 Million | ▼ -74.7% |
| 2008 | 1.16x | CN¥13.01 Million | CN¥11.20 Million | CN¥13.01 Million | — |